ifosfamide ( 1.25 g/m2 intravenously/day x 5 ) with mesna ( 20 % of the ifosfamide dose x six doses on each day of ifosfamide therapy ) was administered to 46 previously treated patients with non-hodgkin 's lymphoma of which 31 were eligible and evaluable .
C0020823
ifosfamide
C0024305
non-hodgkin 's lymphoma